| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/19/2008 | US7413899 Genes from the 20q13 amplicon and their uses |
| 08/19/2008 | US7413898 Cells and methods for estimation of effects on neurological dysfunction |
| 08/19/2008 | US7413897 Culture product; gene therapy for liver disorders |
| 08/19/2008 | US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents |
| 08/19/2008 | US7413889 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 08/19/2008 | US7413875 ESTs and encoded human proteins |
| 08/19/2008 | US7413871 Measuring warm ischemia time, color, fat content, demarcation, and size; feasibility for replacement therapy |
| 08/19/2008 | US7413869 Preparation of immunostimulatory vaccines with activated antigen presenting cells which stimulate a therapeutic T cells response in vivo; used to treat cancer |
| 08/19/2008 | US7413868 Use of particulate labels in bioanalyte detection methods |
| 08/19/2008 | US7413781 Gels for encapsulation of biological materials |
| 08/19/2008 | US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 08/19/2008 | US7413734 Treatment of retinitis pigmentosa with human umbilical cord cells |
| 08/19/2008 | US7413733 Transgenic lymphocytic cells comprising nucleotide sequences which code tumor, bacterial and or viral antigens for use as tools in delivering vaccines to disease bearing tissues |
| 08/19/2008 | US7413732 Baculovirus expression system |
| 08/19/2008 | US7413652 Method for the production of a blood component composition |
| 08/19/2008 | US7412978 Augmentation and repair of vocal cord tissue defects |
| 08/19/2008 | CA2442135C Methods to culture circovirus |
| 08/19/2008 | CA2318372C A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 08/19/2008 | CA2282726C Novel uses of male sterility in plants |
| 08/14/2008 | WO2008098216A2 Compositions and methods to prevent cancer with cupredoxins |
| 08/14/2008 | WO2008098198A2 Alkane oxidation by modified hydroxylases |
| 08/14/2008 | WO2008098184A2 Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof |
| 08/14/2008 | WO2008098042A1 Hybrid cells |
| 08/14/2008 | WO2008097926A2 Transient transfection with rna |
| 08/14/2008 | WO2008097906A2 System and method for forming bone, ligament and bone-ligament constructs |
| 08/14/2008 | WO2008097884A2 Processing skin from living donors |
| 08/14/2008 | WO2008097870A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr) |
| 08/14/2008 | WO2008097866A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 08/14/2008 | WO2008097849A2 Hydrogen gas generators |
| 08/14/2008 | WO2008097828A2 Method for isolating mesenchymal stromal cells |
| 08/14/2008 | WO2008097503A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 08/14/2008 | WO2008097155A1 Media and method for cell separation |
| 08/14/2008 | WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 08/14/2008 | WO2008096868A1 Skin disease model having inflammation and excessive proliferation |
| 08/14/2008 | WO2008096817A1 Gaba neuron progenitor cell marker 65b13 |
| 08/14/2008 | WO2008096781A1 Betacellulin mutein |
| 08/14/2008 | WO2008096745A1 Method for production of hair and biomaterial |
| 08/14/2008 | WO2008096695A1 Dna associated with hydroxylation of vitamin d |
| 08/14/2008 | WO2008096196A1 A medium for cell culture |
| 08/14/2008 | WO2008096118A1 Connective tissue repair |
| 08/14/2008 | WO2008095438A1 Utilizing liver cell line qsg-7701 to be infected with hepatitis b virus |
| 08/14/2008 | WO2008070258A3 Directed differentiation of human embryonic stem cells into mesenchymal/stromal cells |
| 08/14/2008 | WO2008063675A9 Endodermal progenitor cells |
| 08/14/2008 | WO2008045528A3 Methods and compositions for the treatment of cancer |
| 08/14/2008 | WO2008015383A3 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 08/14/2008 | WO2008006104A3 Enhanced oxygen cell culture platforms |
| 08/14/2008 | WO2007080126A9 Dsrna as insect control agent |
| 08/14/2008 | WO2007075921A3 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| 08/14/2008 | US20080196125 Cambium/Xylem-Preferred Promoters and Uses Thereof |
| 08/14/2008 | US20080196124 Plant Growth Hormone Regulated Transcription Factors and Promoters Thereof |
| 08/14/2008 | US20080196122 Rice Cultivar L-206 |
| 08/14/2008 | US20080196120 Genes Involved in Plant Fibre Development |
| 08/14/2008 | US20080196119 Transgenic seed for propagation of disease, insect, freeze, herbicide and drought resistant plants with enhanced carbohydrate and fatty acid metabolism |
| 08/14/2008 | US20080196118 Transgenic seed for propagation of disease, insect and herbicide resistant plants with enhanced fafty acid and carbohydrate metabolism |
| 08/14/2008 | US20080196117 Rice Cultivar M-208 |
| 08/14/2008 | US20080196116 Transgenic seed for propagation of disease resistant legumes |
| 08/14/2008 | US20080196115 Transgenic seed for propagation of disease resistant legumes |
| 08/14/2008 | US20080196112 Using vector transformation to generate cells for use as bioreactor to prepare/express humanized antibodies |
| 08/14/2008 | US20080196111 Expression Vectors and Methods for Obtaining Nk Cell Specific Expression |
| 08/14/2008 | US20080196110 Recombinant non-human mammal expressing mesenchymal-epithelial transition factor (MET) receptor for use as tool in identifying modulators for treatment of cell proliferative disorders |
| 08/14/2008 | US20080194710 Prostatic Stem Cells, Isolation and Uses |
| 08/14/2008 | US20080194701 DNA molecules isolated from Streptococcus agalactiae, comprising genes responsible for gamma -glutamyl-L-cysteinylglycine synthesis; drug design; treatment of infections caused by streptococcus agalactiae |
| 08/14/2008 | US20080194669 T Type Calcium Channel Blockers and the Treatment of Diseases |
| 08/14/2008 | US20080194619 Viricide against retrovirus infection; antiproliferative agents; 4-aminophenyl(1-azabicyclo92.2.2)ocy-4-yl)methanone |
| 08/14/2008 | US20080194540 Desipramine, imipramine, trimipramine, amitriptyline, nortriptyline, doxepin, amoxapine, or maprotyline and chloroquine, promazine, quinine, biquinoline, phenothiazine or chlorpromazine; transfection or gene therapy |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/14/2008 | US20080194521 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 08/14/2008 | US20080194484 Truncated Motilin-Like (TML) peptides; use modulating contractility in duodenum or jejunum tissue and pancreatic secretion of hormones and digestive enzymes |
| 08/14/2008 | US20080194483 GLP-1 (9-36) methods and compositions |
| 08/14/2008 | US20080194481 Albumin Fusion Proteins |
| 08/14/2008 | US20080194477 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 08/14/2008 | US20080194475 mutant erythropoietin (EPO) having improved stability as measured by a ratio of the ability of an EPO variant to bind the EPO receptor in the presence of dithiothreitol (DTT), in a radioimmunoassay, versuses the ability in the absence of DTT in the same radioimmunoassay |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194457 Frizzled Proteins and Detection and Treatment of Cancer |
| 08/14/2008 | US20080194031 Using nanodiamond particles to transfer preferential nucleotide sequences into cells; gene expression analysis; gene therapy |
| 08/14/2008 | US20080194029 Method for Increasing the Ratio of Homologous to Non-Homologous Recombination |
| 08/14/2008 | US20080194026 Commercially viable process for in vitro mass culture of jatropha curcas |
| 08/14/2008 | US20080194025 Stability of Secondary Metabolite Mass Production Through Synchronized Plant Cell Cultures |
| 08/14/2008 | US20080194024 Propagating tissue in nutrient broth comprising glycogen synthase kinase 3 beta inhibitor; tissue culture |
| 08/14/2008 | US20080194023 Generating vascular smooth muscle cells in vitro from ES cells |
| 08/14/2008 | US20080194022 Using notch-4 specific immunoglobulin in treating cell proliferative disorders; immunotherapy |
| 08/14/2008 | US20080194021 Non-embryonic cells differentiate to embryonic lineage |
| 08/14/2008 | US20080194020 Methods For Producing Dendritic Cells That Have Acquired Ctl-Inducing Ability |
| 08/14/2008 | US20080194019 Administering metformin and/or phenformin; for treatment of diabetes and cancer; drug screening |
| 08/14/2008 | US20080194018 Isolated Myeloid-Like Bone Marrow Cell Populations and Methods of Treatment Therewith |
| 08/14/2008 | US20080193998 Modified hydrolase for use in production of riboflavin, riboflavin precursors, riboflavin monophosphate (FMN) and riboflavin 5'adenosine diphosphate (FAD) |
| 08/14/2008 | US20080193980 Fusion protein of Fc-binding domain and calcium-binding photoprotein, gene encoding the same and use thereof |
| 08/14/2008 | US20080193979 Using constitutive hypermutation by vairant DNA repair protein as tool in directed protein evolution |
| 08/14/2008 | US20080193977 Gene Expression Technique |
| 08/14/2008 | US20080193976 Pseudomonas Exotoxin A Cd4+T-Cell Epitopes |
| 08/14/2008 | US20080193975 Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 08/14/2008 | US20080193964 Compositions and methods for regulation of calcium-dependent signaling in brain |
| 08/14/2008 | US20080193944 Expression vector comprising nucleotide sequences coding cardiac-related ankyrin-repeat protein kinase (CARK) for diagnosis, treatment and prevention of cardiovascular disorders |
| 08/14/2008 | US20080193942 Homogeneous primary erythroblast population from bone marrow with upregulated sialoglycoprotein expression (podocalyxin); anti-anemia agent; cytoprotective factor for injured heart, endothelial, neuronal and renal cells |
| 08/14/2008 | US20080193932 Methods Of Inhibiting the Activity of Hsp90 and/or Aryl Hydrocarbon Receptor |
| 08/14/2008 | US20080193925 Thermostable Y-Family Polymerases and Chimeras |
| 08/14/2008 | US20080193924 Reacting astemizole with potassium channel moderators; complexing; calibration; kits |
| 08/14/2008 | US20080193910 Primary muscle cells on substrate without disposing cells within an exogenous scaffold; cultured in vitro to form a confluent monolayer; at least two anchors spaced; secondary tissue in contact with monolayer; detaches from substrate, self-organizes, surrounds secondary tissue; three-dimension interface |
| 08/14/2008 | US20080193507 Wound Healing Profile |
| 08/14/2008 | US20080193505 Nutritional Compositions For Modulating Vitamin C Bio-Availability |